Alpha2C-adrenoceptor overexpression disrupts execution of spatial and non-spatial search patterns

Neuroscience

Volumn 88, Issue 4, 1999, Pages 1187-1198

  Bjorklund M ^a   Sirvio J ^a   Sallinen, J ^b   Scheinin, M ^b   Kobilka, B K ^c   Riekkinen Jr, P ^d  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c STANFORD UNIVERSITY   (United States)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alpha2 antagonist; Alpha2C adrenergic receptor; Benzodiazepine; Executive function; Search pattern; Spatial and non spatial navigation

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ATIPAMEZOLE; DIAZEPAM;

ACCURACY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPATIAL DISCRIMINATION; SWIMMING;

EID: 0345055323     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00306-6     Document Type: Article

References (49)

1. Annett L. E., McGregor A., Robbins T. W. The effects of ibotenic acid lesions of the nucleus accumbens on spatial learning and extinction in the rat. Behav. Brain Res. 31:1989;231-242.
2. Arnsten A. F. T., Cai J. X., Goldman-Rakic P. S. The α-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for α-2 receptor subtypes. J. Neurosci. 8:1988;4287-4298.
3. Arnsten A. F. T., Goldman-Rakic P. S. Alpha-2 adrenergic mechanism in prefrontal cortex associated with cognitive decline in aged nonhuman primates. Science. 230:1985;1273-1376.
4. Arnsten A. F. T., Leslie F. M. Behavioural and receptor binding analysis of the α-2 adrenergic agonist, UK-14304 (5 bromo-6 (2-imidazoline-2-yl amino) quinoxaline); evidence for cognitive enhancement at an α-2 adrenoceptor subtype. Neuropharmacology. 30:1991;1279-1289.
5. Arnsten A. F. T., Steere J. C., Hunt R. D. The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Archs gen. Psychiat. 53:1996;448-455.
6. Björklund M., Sirviö J., Riekkinen M., Puoliväli J., Sallinen J., Scheinin M., Haapalinna A., Kobilka B. K., Santtila P. and Riekkinen P. Jr. (1996) Alpha 2C-adrenoceptor overexpression impairs development of normal water maze search strategy in mice. Abstracts of 26th Annual Meeting Society for Neuroscience, Washington D.C.
7. Brozoski T. J., Brown R. M., Rosvold H. E., Goldman P. S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of Rhesus monkey. Science. 215:1979;929-932.
8. Bylund D. B. Subtypes of alpha-2 adrenoceptors: pharmacological and molecular biological evidence convergence. Trends pharmac. Sci. 9:1988;356-361.
9. Clark C. R., Geffen G. M., Geffen L. B. Catecholamines and the covert orientation of attention in humans. Neuropsychologia. 27:1989;131-139.
10. Cole J. C., Rodgers R. J. Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behavior of mice in the elevated plus maze. Pharmac. Biochem. Behav. 52:1995;473-478.
11. Coull J. T. Pharmacological manipulations of the α2-noradrenergic system: effects on cognition. Drugs Aging. 5:1994;116-126.
12. Coull J. T., Middleton H. C., Robbins T. W., Sahakian B. J. Contrasting effects of clonidine and diazepam on tests of working memory and planning. Psychopharmacology, Berlin. 120:1995;311-321.
13. Crow T. J. Cortical synapses and reinforcement. Nature. 219:1968;736-737.
14. de Sarro G. B., Ascioti C., Froio F., Libri V., Nistico G. Evidence that locus coeruleus is the site where clonidine and drugs acting at alpha 1- and alpha 2-adrenoceptors affect sleep and arousal mechanisms. Br. J. Pharmac. 90:1987;675-685.
15. Fillenz M. (1990) Noradrenergic neurons. Cambridge University Press, Cambridge.
16. Frith C. D., Dowdy J., Ferrier I. N., Crow T. J. Selective impairment of paired associate learning after administration of a centrally-acting adrenergic agonist (clonidine). Psychopharmacology, Berlin. 87:1985;490-493.
17. Gerlai R. Molecular genetic analysis of mammalian behavior and brain processes: caveats and perspectives. Semin. Neurosci. 8:1996;153-161.
18. Kelley A. E., Domesick V. B. The distribution of projection from the hippocampal formation to the nucleus accumbens in the rat: an anterograde- and retrograde-horseradish peroxidase study. Neuroscience. 7:1982;2321-2335.
19. Kety S. S. (1970) The biogenic amines and the central nervous system: Their possible roles in arousal, emotion and learning. In The Neurosciences, Second Study Program (ed. Schmidt F. O.), pp. 324-336. Rockefeller University Press, New York.
20. Lanier S. M., Downing S., Duzic E., Homcy C. J. Isolation of rat genomic clones encoding subtypes of the alpha 2-adrenergic receptor. Identification of a unique receptor subtype. J. biol. Chem. 266:1991;10470-10478.
21. 2-adrenoceptor-subtype function. Trends pharmac. Sci. 18:1997;211-219.
22. McCormick D. A., Pape H. C., Williamson A. Actions of norepinephrine in the cerebral cortex and thalamus: implications for function of the central noradrenergic system. Prog. Brain Res. 88:1991;293-305.
23. McDonald R. J., White N. M. Parallel information processing in the water maze: evidence for independent memory systems involving dorsal striatum and hippocampus. Behav. neural Biol. 61:1994;260-270.
24. McNamara R. K., Skelton R. W. Diazepam impairs acquisition but not performance in the Morris water maze. Pharmac. Biochem. Behav. 38:1991;651-658.
25. Mileson B. E., Schwartz R. D. The use of locomotor activity as behavioral screen for neuronal damage following transient forebrain ischemia in gerbils. Neurosci. Lett. 128:1991;71-76.
26. Morris R. G. M. Spatial localization does not require the presence of local cues. Learn. Motiv. 12:1981;239-261.
27. Morris R. G. M. Developments of a water-maze procedure for studying spatial learning in rats. J. Neurosci. Meth. 11:1984;47-60.
28. Nicholas A. P., Hökfelt T., Pieribone V. A. The distribution and significance of CNS adrenoceptors examined with in situ hybridization. Trends pharmac. Sci. 17:1996;245-255.
29. Nicholas A. P., Pieribone V., Hökfelt T. Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. J. comp. Neurol. 328:1993;575-594.
30. O'Donnell P., Grace A. A. Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input. J. Neurosci. 15:1995;3622-3639.
31. Puurunen K., Sirviö J., Koistinaho J., Miettinen R., Haapalinna A., Riekkinen P. Sr., Sivenius J. Studies on the influence of enriched-environment housing combined with systemic administration of an alpha2-adrenergic antagonist on spatial learning and hyperactivity after global ischemia in rats. Stroke. 28:1997;623-631.
32. Rämä P., Linnankoski I., Tanila H., Pertovaara A., Carlson S. Medetomidine, atipamezole, and guanfacine in delayed response performance of aged monkeys. Pharmac. Biochem. Behav. 55:1996;415-422.
33. Riekkinen M., Riekkinen P. Jr. Dorsal hippocampal muscarinic acetylcholine and NMDA receptors disrupt water maze navigation. NeuroReport. 8:1997;645-648.
34. Riekkinen P. Jr., Sirviö J., Jäkälä P., Lammintausta R., Riekkinen P. Effect of alpha2 antagonists and an agonist on EEG slowing induced by scopolamine and lesion of the nucleus basalis. Neuropharmacology. 29:1990;993-999.
35. Riekkinen P. Jr., Sirviö J., Riekkinen M., Lammintausta R., Riekkinen P. Atipamezole, an alpha 2 antagonist, stabilizes age-related high-voltage spindle and passive avoidance defects. Pharmac. Biochem. Behav. 41:1992;611-614.
36. Rosin D. L., Talley E. M., Lee A., Stornetta R. L., Gaylinn R. D., Guyenet P. G., Lynch K. R. Distribution of α2C-adrenergic receptor-like immunoreactivity in the rat central nervous system. J. comp. Neurol. 372:1996;135-165.
37. Sahakian B. J., Coull J. T., Hodges J. R. Selective enhancement of executive function by idazoxan in a patient with dementia of the frontal lobe type. J. Neurol. Neurosurg. Psychiat. 57:1994;120-121.
38. Sallinen J., Link R. E., Haapalinna A., Viitamaa T., Kulatunga M., Sjöholm B., MacDonald E., Pelto-Huikko M., Leino T., Barsh G. S., Kobilka B. K., Scheinin M. Genetic alteration of alpha-2C-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective alpha-2C-adrenoceptor agonist. Molec. Pharmac. 51:1997;36-46.
39. Sara S. J., Vankov A., Herve A. Locus coeruleus-evoked responses in behaving rats: a clue to the role of noradrenaline in memory. Brain Res. Bull. 35:1994;457-465.
40. Scheel-Krüger J. and Willner P. (1991) The Mesolimbic Dopamine System: From Motivation To Action. (eds Willner P. and Scheel-Krüger J.) pp. 560-597. John Wiley and Sons Ltd, London.
41. 2-adrenoceptor antagonist. Eur. J. Pharmac. 151:1988;35-42.
42. Scheinin M., Lomasney J. W., Hayden-Hixson D. M., Schambra U. B., Caron M. G., Lefkowitz R. J., Fremeau R. T. Distribution of α-2 adrenergic receptor subtype gene expression in rat brain. Molec. Brain Res. 21:1994;133-149.
43. Sesack S. R., Deutch A. Y., Roth R. H., Bunney B. S. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J. comp. Neurol. 290:1989;213-242.
44. Sirviö J., Jäkälä P., Mazurkiewicz M., Haapalinna A., Riekkinen P. Jr., Riekkinen P. J. Dose- and parameter-dependent effects of atipamezole, an alpha 2-antagonist, on the performance of rats in a five-choice serial reaction time task. Pharmac. Biochem. Behav. 45:1993;123-129.
45. 2 agonist, on learning and memory, assessed using passive avoidance and water maze tasks in rats. Neuropharmacology. 31:1992;163-168.
46. Sirviö J., Riekkinen P. Jr., Vajanto I., Koivisto E., Riekkinen P. J. The effects of guanfacine, α-2 agonist, on the performance of young and aged rats in spatial navigation task. Behav. neural Biol. 56:1991;101-107.
47. 2-adrenoceptor antagonist idazoxan on mood, memory and attention in normal volunteers. J. Psychopharmac. 6:1992;376-381.
48. 2-adrenoceptors by atipamezole. Archs int. Pharmacodyn. Thér. 297:1989;190-204.
49. Whishaw I. Q. Dissociating performance and learning deficits on spatial navigation tasks in rats subjected to cholinergic muscarinic blockade. Brain Res. Bull. 23:1989;347-358.